Sphingosine 1‐phosphate is a ligand for peroxisome proliferator‐activated receptor‐γ that regulates neoangiogenesis
暂无分享,去创建一个
G. Tigyi | K. Tooley | S. Pitson | L. M. Moldenhauer | C. Bonder | Michaelia P Cockshell | B. Gliddon | J. R. Zebol | Kate A. Parham | W. Y. Sun | P. A. Moretti | P. Moretti | Briony L. Gliddon | Julia R. Zebol | Briony L Gliddon
[1] Cheng Luo,et al. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5 , 2014, Nature Immunology.
[2] S. Erzurum,et al. Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. , 2013, The American journal of pathology.
[3] Jiandie D. Lin,et al. Peroxisome Proliferator-activated Receptor γ Coactivator 1β (PGC-1β) Protein Attenuates Vascular Lesion Formation by Inhibition of Chromatin Loading of Minichromosome Maintenance Complex in Smooth Muscle Cells* , 2012, The Journal of Biological Chemistry.
[4] P. Dentelli,et al. Increase of Palmitic Acid Concentration Impairs Endothelial Progenitor Cell and Bone Marrow–Derived Progenitor Cell Bioavailability , 2012, Diabetes.
[5] Angel F. Lopez,et al. Characterization of a Distinct Population of Circulating Human Non-Adherent Endothelial Forming Cells and Their Recruitment via Intercellular Adhesion Molecule-3 , 2012, PloS one.
[6] S. Corvera,et al. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial , 2012, Diabetologia.
[7] V. Christiaens,et al. CD36 promotes adipocyte differentiation and adipogenesis. , 2012, Biochimica et biophysica acta.
[8] J. Pfeilschifter,et al. Thiazolidinedione‐dependent activation of sphingosine kinase 1 causes an anti‐fibrotic effect in renal mesangial cells , 2012, British journal of pharmacology.
[9] A. Nurul,et al. The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells , 2012, Clinical & developmental immunology.
[10] M. Hickey,et al. Rapid histamine-induced neutrophil recruitment is sphingosine kinase-1 dependent. , 2012, The American journal of pathology.
[11] Eugene Y. Kim,et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.
[12] S. Pitson,et al. Over‐Expression of Sphingosine Kinase‐1 Enhances a Progenitor Phenotype in Human Endothelial Cells , 2011, Microcirculation.
[13] T. Itakura,et al. Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model , 2011, PloS one.
[14] Cholsoon Jang,et al. PGC-1β regulates angiogenesis in skeletal muscle. , 2011, American journal of physiology. Endocrinology and metabolism.
[15] Jiandie D. Lin,et al. PGC-1 coactivators in the control of energy metabolism. , 2011, Acta biochimica et biophysica Sinica.
[16] S. Pitson. Regulation of sphingosine kinase and sphingolipid signaling. , 2011, Trends in biochemical sciences.
[17] D. C. Simpson,et al. Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] S. Pitson,et al. Tumor necrosis factor-induced neutrophil adhesion occurs via sphingosine kinase-1-dependent activation of endothelial {alpha}5{beta}1 integrin. , 2010, The American journal of pathology.
[19] Cheng Luo,et al. SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.
[20] C. Glass,et al. Pharmacological correction of a defect in PPARγ signaling ameliorates disease severity in Cftr-deficient mice , 2010, Nature Medicine.
[21] R. Proia,et al. Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver* , 2010, The Journal of Biological Chemistry.
[22] J. Gamble,et al. Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival. , 2009, The American journal of pathology.
[23] Cheng Luo,et al. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.
[24] F. Goñi,et al. Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments. , 2009, Biophysical journal.
[25] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[26] J. Gamble,et al. Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation. , 2009, Blood.
[27] Y. Hannun,et al. Role for sphingosine kinase 1 in colon carcinogenesis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] F. Orso,et al. Formation of STAT5/PPARγ Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[29] Hsinyu Lee,et al. Prostaglandins and Other Lipid Mediators ysophosphatidic acid-induced oxidized low-density lipoprotein ptake is class A scavenger receptor-dependent in macrophages , 2008 .
[30] T. Karn,et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer , 2008, Breast Cancer Research and Treatment.
[31] T. Hla,et al. The vascular S1P gradient-cellular sources and biological significance. , 2008, Biochimica et biophysica acta.
[32] Barbara S. Paugh,et al. Sphingosine-1-Phosphate and Interleukin-1 Independently Regulate Plasminogen Activator Inhibitor-1 and Urokinase-Type Plasminogen Activator Receptor Expression in Glioblastoma Cells: Implications for Invasiveness , 2008, Molecular Cancer Research.
[33] Peter Tontonoz,et al. Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.
[34] V. Limaye. The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology. , 2008, Endothelium : journal of endothelial cell research.
[35] G. Yan,et al. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids. , 2008, Cardiovascular research.
[36] N. Sugimoto,et al. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice. , 2008, Cardiovascular research.
[37] J. Pfeilschifter,et al. Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. , 2008, Biochemical and biophysical research communications.
[38] Chulhee Choi,et al. Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species. , 2008, Immunology letters.
[39] M. Vadas,et al. Eukaryotic Elongation Factor 1A Interacts with Sphingosine Kinase and Directly Enhances Its Catalytic Activity* , 2008, Journal of Biological Chemistry.
[40] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[41] A. Margeli,et al. Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis , 2007, Expert opinion on investigational drugs.
[42] U. Laufs,et al. The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance , 2007, Diabetes.
[43] Chiung-Nien Chen,et al. Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. , 2007, Biochemical and biophysical research communications.
[44] B. Spiegelman,et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.
[45] W. Garvey,et al. Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. , 2006, Atherosclerosis.
[46] Satoshi Yasuda,et al. Different Residues Mediate Recognition of 1-O-Oleyllysophosphatidic Acid and Rosiglitazone in the Ligand Binding Domain of Peroxisome Proliferator-activated Receptor γ* , 2006, Journal of Biological Chemistry.
[47] R. Proia,et al. Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.
[48] J. Passauer,et al. PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells , 2005 .
[49] Korey R. Johnson,et al. Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[50] Thomas W Prior,et al. Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines , 2005, Journal of neuropathology and experimental neurology.
[51] Matej Oresic,et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. , 2005, Diabetes.
[52] J. Gamble,et al. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. , 2005, Blood.
[53] T. Wurch,et al. Human Adipocyte Fatty Acid-Binding Protein (aP2) Gene Promoter-Driven Reporter Assay Discriminates Nonlipogenic Peroxisome Proliferator-Activated Receptor γ Ligands , 2004, Journal of Pharmacology and Experimental Therapeutics.
[54] T. Hla. Physiological and pathological actions of sphingosine 1-phosphate. , 2004, Seminars in cell & developmental biology.
[55] M. Al-Omran,et al. Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage: A New Paradigm in Glitazone Pleiotropy , 2004, Circulation.
[56] I. Morita,et al. Expression and function of PPARγ in rat placental development , 2004 .
[57] M. Tötsch,et al. Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1). , 2004, Cancer letters.
[58] J. C. Hinshaw,et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] M. Vadas,et al. The Nucleotide-binding Site of Human Sphingosine Kinase 1* , 2002, The Journal of Biological Chemistry.
[60] T. Panetti. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. , 2002, Biochimica et biophysica acta.
[61] Y. Kawahito,et al. Expression of peroxisome proliferator‐activated receptor (PPAR) in human prostate cancer , 2002, The Prostate.
[62] B. Spiegelman,et al. PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth* , 2001, The Journal of Biological Chemistry.
[63] J. Gamble,et al. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. , 2000, The Biochemical journal.
[64] M. Fujishima,et al. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. , 2000, Biochimica et biophysica acta.
[65] M. Lazar,et al. A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis* , 2000, The Journal of Biological Chemistry.
[66] Y. G. Kwon,et al. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. , 1999, Biochemical and biophysical research communications.
[67] B. Spiegelman,et al. Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer , 1999 .
[68] M. Gerritsen,et al. Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo * , 1999, The Journal of Biological Chemistry.
[69] P. Libby,et al. PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression PPARγ as a Potential Mediator in Vascular Disease , 1999 .
[70] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[71] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[72] C. H. Liu,et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.
[73] B. Spiegelman,et al. Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.
[74] A. Daugherty,et al. Scavenger receptors are present on rabbit aortic endothelial cells in vivo. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[75] J. Gamble,et al. Novel Cytokine-independent Induction of Endothelial Adhesion Molecules Regulated by Platelet/Endothelial Cell Adhesion Molecule (CD31) , 1997, The Journal of cell biology.
[76] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[77] J. Flier,et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. , 1997, The Journal of biological chemistry.
[78] Y. Igarashi,et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.
[79] R. Hantgan,et al. Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: evidence for a key role of endothelial cells in thrombolytic resistance. , 1996, Blood.
[80] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[81] T. Wick,et al. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. , 1992, Journal of immunology.
[82] B. Zetter,et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.
[83] M. Brown,et al. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[84] J. Folkman,et al. TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION , 1972, The Journal of experimental medicine.
[85] W. Daniel,et al. Telmisartan prevents VCAM-1 induction and monocytic cell adhesion to endothelium exposed to non-uniform shear stress and TNF-α. , 2011, Clinical hemorheology and microcirculation.
[86] M. Maceyka,et al. Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.
[87] J. Passauer,et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. , 2005, Atherosclerosis.
[88] I. Morita,et al. Expression and function of PPARgamma in rat placental development. , 2004, Biochemical and biophysical research communications.
[89] A. Margeli,et al. Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis , 2004, Angiogenesis.
[90] B. Spiegelman,et al. PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. , 2001, The Journal of biological chemistry.
[91] R. Evans,et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.
[92] M. Lazar,et al. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. , 2000, The Journal of biological chemistry.
[93] P. Libby,et al. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[94] R. Evans,et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.